血清尿酸与动脉样性疾病之间的因果关系:孟德尔随机化和转录组分析
Shitao Wang1,2, Shuai Mei1,2, Xiaozhu Ma1,2
1Division of Cardiology, Departments of Internal Medicine, Tongji Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China.
Biomedicines
|August 28, 2025
概括
高血清尿酸水平与冠心病 (CHD) 有因果关系. 这种关系部分由血压和甘油三调节,这表明尿酸控制可能有利于心脏病患者.
科学领域:
- 心血管医学
- 遗传学
- 代谢疾病
背景情况:
- 血清尿酸升高与冠状动脉疾病 (CHD) 的发生,发展和不良事件有关.
- 尿酸在冠状动脉疾病中的直接致病作用和风险因素的介导作用尚不清楚.
研究的目的:
- 评估血清尿酸与心血管疾病之间的潜在因果关系.
- 研究心血管疾病风险因素在尿酸与心血管疾病的关系中的调解作用.
主要方法:
- 孟德尔随机分析 (MR) 来评估因果关系.
- 贝叶斯定位用于分析遗传工具变性.
- 两个阶段的MR用于识别介导风险因素.
- 转录组分析以探索机制.
主要成果:
- 核磁共振分析证实血清尿酸与冠状动脉疾病,稳定性心痛和心肌梗塞之间存在显著的因果关系.
- 扩张血压,平均动脉压和血清甘油三部分介导这种因果关系.
- 转录学数据表明尿酸可能通过改变巨细胞基因表达直接促进动脉样硬化.
结论:
- 对于长期治疗心脏病患者来说,血清尿酸度控制可能是必不可少的.
- 需要进一步的临床试验和研究来证实尿酸减少对心血管的益处.
相关概念视频
Genome-wide Association Studies-GWAS
14.1K
Genome-wide association studies or GWAS are used to identify whether common SNPs are associated with certain diseases. Suppose specific SNPs are more frequently observed in individuals with a particular disease than those without the disease. In that case, those SNPs are said to be associated with the disease. Chi-square analysis is performed to check the probability of the allele likely to be associated with the disease.
GWAS does not require the identification of the target gene involved in...
GWAS does not require the identification of the target gene involved in...
14.1K
Coronary Artery Disease I: Introduction
54
Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
54
Atherosclerosis III: Management
33
Management of atherosclerosis involves an integrated strategy encompassing pharmacological treatment, surgical interventions, lifestyle changes, and nutrition therapy to address the multifactorial nature of the disease.Pharmacological TherapyA cornerstone of atherosclerosis management is the use of pharmacological agents. Statins, such as atorvastatin, are pivotal in inhibiting HMG-CoA reductase, an enzyme that catalyzes an initial step in cholesterol synthesis in the liver. This reduction in...
33
Atherosclerosis I: Introduction
76
Atherosclerosis is a progressive disorder characterized by the buildup of plaques on the arterial inner wall, causing them to narrow and harden over time. These plaques comprise lipids, calcium, blood components, carbohydrates, and fibrous tissue. The process primarily affects the intima of large and medium-sized arteries, reducing blood flow in any artery.Etiology and risk factorsThe cause of atherosclerosis is multifactorial, involving a complex interplay among endothelial injury, lipid...
76
Atherosclerosis II: Clinical Manifestations and Diagnostic Tests
38
Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...
38
Coronary Artery Disease II: Pathophysiology
33
Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
33


